Characterization of receptors interacting specifically with the B-chain of tissue plasminogen activator on endothelial cells

Fibrinolysis

Volumn 10, Issue 3, 1996, Pages 167-175

  Cheng, X F ^a   Pohl, G ^a   Back O ^a   Wallen P ^a  

^a UMEÅ UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ALTEPLASE; BINDING PROTEIN; IODINE 125; PLASMINOGEN ACTIVATOR INHIBITOR 1; RECOMBINANT PLASMINOGEN ACTIVATOR; TISSUE PLASMINOGEN ACTIVATOR;

AFFINITY CHROMATOGRAPHY; ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; ENDOTHELIUM CELL; FIBRINOLYSIS; HUMAN; HUMAN CELL; ISOTOPE LABELING; PLASMINOGEN ACTIVATION; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN CROSS LINKING; VASCULAR ENDOTHELIUM;

EID: 0029931649     PISSN: 02689499     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0268-9499(96)80028-2     Document Type: Article

References (29)

1. Carmeliet P, Schoonjans L, Kieckens L et al. Physiological consequences of loss of plasminogen activator gene function in mice. Nature 1994; 368: 419-24.
2. Miles L A, Plow E F. Plasminogen receptors: Ubiquitous sites for cellular regulation of fibrinolysis. Fibrinolysis 1988; 2: 61-71.
3. Hajjar K A, Harpel P C, Jaffe E A, Nachman R L Binding of plasminogen to cultured human endothelial cells. J Biol Chem 1986; 261: 11656-662.
4. Dudani A K, Cummings C, Hashemi S, Ganz P R. Isolation of a novel 45 kDa plasminogen receptor from human endothelial cells. Thromb Res 1993; 69: 185-96.
5. Liu C Y, Wallén P, Handley D A, Smith J. Fibrin potentiation of plasminogen activation by tissue plasminogen activator on bovine endothelial cell surface. In: Muller-Berghaus G, Schefers-Borchel U, Selmayr E, Henschen A, Eds. Fibrinogen and its derivatives. Amsterdam: Excerpta Medica, 1986; 319-22.
6. Hajjar K A, Hamel, N M, Harpel P.C, Nachman R.L Binding of tissue plasminogen activator to cultured human endothelial cells. J Clin Invest 1987; 80: 1712-19.
7. Barnathan E S, Kuo A, Van der Keyl H, McCrae K R, Larsen G R, Cines D B. Tissue-type plasminogen activator binding to human endothelial cells. Evidence for two distinct binding sites. J Biol Chem 1988; 263: 7792-99.
8. Aerts R J, Gillis K, Pannekoek H. Single-chain and two-chain tissue-type plasminogen activator (t-PA) bind differently to cultured human endothelial cells. Thromb Haemost 1989; 62: 699-703.
9. Hajjar K A, Hamel N M. Identification and characterization of human endothelial cell membrane binding sites for tissue plasminogen activator and urokinase. J Biol Chem 1990; 265: 2908-16.
10. Beebe D P, Wood L L, Moos M. Characterization of tissue plasminogen activator binding proteins isolated from endothelial cells and other cell types. Thromb Res 1990; 59: 339-50.
11. Fukao H, Hagiya Y, Nonaka T, Okada K, Matsuo O. Analysis of binding protein for tissue-type plasminogen activator in human endothelial cells. Biochem Biophys Res Comm 1992; 187: 956-62.
12. Cheng X-F, Bäck O, Nilsson T K, Nylander Lundqvist E, Pohl G, Wallen P. Binding of tissue plasminogen activator to human endothelial cells. Importance of the B-chain as a ligand. Biochem J 1992; 287:, 407-13.
13. Cheng X-F, Brohlin M, Pohl G, Bäck O, Wallén P. Binding of tissue plasminogen activator to endothelial cells. The effect on functional properties. Localization of a ligand in the B-chain of t-PA. Thromb Res 1995; 77: 149-64.
14. Dudani A K, Pluskota A, Ganz P R. Interaction of tissue plasminogen activator with a human endothelial cell 45-kilodalton plasminogen receptor. Biochem Cell Biol 1994; 72: 126-31.
15. Hajjar K A, Jacovina A T, Chacko J. An endothelial cell receptor for plasminogen/tissue plasminogen activator. I. Identity with annexin II. J Biol Chem 1994; 269: 21191-197.
16. Mandriota S J, Seghezzi G, Vassalli J-D et al. Vascular endothelial growth factor increases urokinase receptor expression in vascular endothelial cells. J Biol Chem 1995; 270: 9709-16.
17. Mimuro J, Loskutoff D J. Purification of a protein from bovine plasma that binds to type 1 plasminogen activator inhibitor and prevents its interaction with extracellular matrix. Evidence that the protein is vitronectin. J Biol Chem 1989; 264: 936-39.
18. Schleef R R, Podor T J, Dunne E, Mimuro J, Loskutoff D J. The majority of type 1 plasminogen activator inhibitor associated with cultured human endothelial cells is located under the cells and is accessible to solution-phased tissue plasminogen activator. J Cell Biol 1990; 110: 155-63.
19. WallÈn P, Bergsdorf N, Rånby M. Purification and identification of two structural variants of porcine tissue plasminogen activators by affinity adsorbtion on fibrin. Biochim Biophys Acta 1982; 719: 318-28.
20. Björkquist P, Brohlin M, Ehnebom J et al. Plasminogen activator inhibitor type-1 interacts exclusively with the proteinase domain of tissue plasminogen activator. Biochim Biophys Acta 1974; 1209: 191-202.
21. Strömqvist M, Andersson J-O, Boström S et al. Separation of active and inactive forms of recombinant human plasminogen activator inhibitor type l (PA1-1) expressed in Chinese hamster ovary cells: Comparison with native human PAI-1. Protein Expression and Purification 1994; 5: 309-16.
22. Ades E W, Candal F J, Swerlick R A et al. HMEC-1: Establishment of an immortalized human microvascular endothelial cell line. J.Invest Dermatol 1992; 99: 683-90.
23. Bordier C. Phase separation of integral membrane proteins in Triton X-114 solution. J Biol Chem 1981; 256: 1604-07.
24. Laemmli U K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970; 227: 680-85.
25. Rånby M. Studies on the kinetics of plasminogen activaton by tissue plasminogen activator. Biochim Biophys Acta 1982; 704: 461-69.
26. Hajjar K A. The endothelial cell tissue plasminogen activator receptor. Specific interaction with plasminogen. J Biol Chem 1991; 266: 21962-970.
27. Cesarman G M, Guevara C A, Hajjar K A. An endothelial cell receptor for plasminogen/tissue plasminogen activator (t-PA). II. Annexin II-mediated enhancement of t-PA-dependent plasminogen activation. J Biol Chem 1994; 269: 21198-203.
28. Beebe D P, Miles L A, Plow E F. A linear amino acid sequence involved in the interaction of t-PA with its endothelial cell receptor. Blood 1989; 74: 2034-37.
29. Madison E L, Goldsmith E J, Gerard R D, Gething M-J H, Sambrook J.F. Serpin-resistant mutants of human tissue-type plasminogen activator. Nature 1989; 339: 721-24.